tiprankstipranks
Art'S-Way Manufacturing Co. (ARTW)
NASDAQ:ARTW
Want to see ARTW full AI Analyst Report?

Art's-Way Manufacturing Co (ARTW) AI Stock Analysis

140 Followers

Top Page

ARTW

Art's-Way Manufacturing Co

(NASDAQ:ARTW)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
$2.50
▲(6.38% Upside)
Action:Reiterated
Date:04/23/26
ARTW scores mid-range primarily due to weak cash generation (negative TTM operating cash flow and free cash flow) despite improved margins and a healthier balance sheet. Technicals are strong with price above major moving averages and a positive MACD, but overbought RSI/Stoch readings add near-term risk. Valuation is moderate on P/E, while recent corporate actions are mildly supportive but not a major fundamental driver.
Positive Factors
Improved Profitability
Margin expansion and positive TTM revenue growth indicate improved cost absorption and operating discipline. Sustained mid-20% gross margins and double-digit EBITDA margin provide structural breathing room to fund reinvestment and aftermarket support across farming cycles.
Negative Factors
Weak Cash Generation
Persistent negative operating and free cash flow despite profit improvement signals weak cash conversion and working capital volatility. This constrains internal funding for parts inventory, dealer credit support, or sustainable reinvestment without external financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Profitability
Margin expansion and positive TTM revenue growth indicate improved cost absorption and operating discipline. Sustained mid-20% gross margins and double-digit EBITDA margin provide structural breathing room to fund reinvestment and aftermarket support across farming cycles.
Read all positive factors

Art's-Way Manufacturing Co (ARTW) vs. SPDR S&P 500 ETF (SPY)

Art's-Way Manufacturing Co Business Overview & Revenue Model

Company Description
Art's-Way Manufacturing Co., Inc. (ARTW) specializes in the production and distribution of a diverse range of products, including agricultural equipment, bespoke modular scientific facilities, and precision steel cutting tools, serving both domest...
How the Company Makes Money
Art's-Way makes money by manufacturing and selling equipment and related parts/services across its operating segments. Revenue is primarily generated from (1) sales of agricultural machinery and equipment to a dealer network and end customers, wit...

Art's-Way Manufacturing Co Financial Statement Overview

Summary
Profitability has improved in the TTM period (revenue +6.5%, ~26.9% gross margin, ~5.3% net margin, ~11.3% EBITDA margin) and leverage is manageable with lower debt-to-equity (~0.31). However, the biggest drag is cash conversion: TTM operating cash flow and free cash flow are negative (about -$0.65M and -$1.38M), and revenue has been choppy across recent annual periods.
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
34
Negative
BreakdownTTMNov 2025Nov 2024Nov 2023Nov 2022Nov 2021
Income Statement
Total Revenue24.47M22.98M24.50M30.28M25.65M24.97M
Gross Profit6.59M5.92M7.31M8.58M6.94M6.60M
EBITDA2.98M2.60M1.45M2.48M1.51M1.19M
Net Income1.29M1.03M307.38K266.97K97.80K212.63K
Balance Sheet
Total Assets24.56M22.48M21.24M24.40M23.95M20.85M
Cash, Cash Equivalents and Short-Term Investments2.94K4.85K1.86K4.01K5.05K2.66K
Total Debt6.48M6.41M4.78M8.15M7.40M7.04M
Total Liabilities11.02M9.17M9.15M12.76M12.80M10.50M
Stockholders Equity13.55M13.31M12.09M11.64M11.15M10.35M
Cash Flow
Free Cash Flow-1.38M-1.53M1.90M-896.98K-717.76K-1.61M
Operating Cash Flow-653.94K-904.14K2.63M-55.19K951.72K-985.85K
Investing Cash Flow-670.06K-580.48K961.07K-453.51K-1.34M-599.48K
Financing Cash Flow1.32M1.49M-3.59M507.67K394.52K1.59M

Art's-Way Manufacturing Co Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.35
Price Trends
50DMA
2.66
Negative
100DMA
2.48
Positive
200DMA
2.51
Positive
Market Momentum
MACD
<0.01
Positive
RSI
45.64
Neutral
STOCH
25.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARTW, the sentiment is Neutral. The current price of 2.35 is below the 20-day moving average (MA) of 2.62, below the 50-day MA of 2.66, and below the 200-day MA of 2.51, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 45.64 is Neutral, neither overbought nor oversold. The STOCH value of 25.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ARTW.

Art's-Way Manufacturing Co Risk Analysis

Art's-Way Manufacturing Co disclosed 2 risk factors in its most recent earnings report. Art's-Way Manufacturing Co reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks

Art's-Way Manufacturing Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$219.87M14.447.08%-11.11%-6.38%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
$42.61M-1.80-86.90%5.46%68.00%
58
Neutral
$13.42M10.3515.99%2.33%3786.15%
48
Neutral
$60.13M-5.15-56.78%294.11%50.33%
40
Underperform
$4.25M-0.01-32.29%-30.80%-317.49%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARTW
Art's-Way Manufacturing Co
2.59
0.77
42.31%
GENC
Gencor
15.00
0.61
4.24%
HYFM
Hydrofarm Holdings Group
0.89
-3.00
-77.10%
XOS
Xos
3.12
0.11
3.65%
RYM
RYTHM
27.98
7.97
39.83%

Art's-Way Manufacturing Co Corporate Events

Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Art’s-Way Shareholders Approve Directors, Auditor and Equity Plan
Positive
Apr 22, 2026
On April 21, 2026, Art&#8217;s-Way Manufacturing Co., Inc. held its 2026 Annual Meeting of Stockholders, where shareholders elected five directors to the board and ratified the appointment of Eide Bailly LLP as independent auditor for the fiscal y...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 23, 2026